• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Response to COVID-19 and diabetes: Can DPP4 inhibition play a role? - GLP-1 might play one too.

作者信息

Morin Nathaniel

机构信息

Pharmacy Services, South Health Campus, 4448 Front St SE, Calgary, Alberta, T3M 1M4, Canada.

出版信息

Diabetes Res Clin Pract. 2020 Jun;164:108160. doi: 10.1016/j.diabres.2020.108160. Epub 2020 Apr 22.

DOI:10.1016/j.diabres.2020.108160
PMID:32333969
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7175913/
Abstract
摘要

相似文献

1
Response to COVID-19 and diabetes: Can DPP4 inhibition play a role? - GLP-1 might play one too.对2019冠状病毒病（COVID-19）的反应与糖尿病：二肽基肽酶4（DPP4）抑制能否发挥作用？-胰高血糖素样肽1（GLP-1）可能也起作用。
Diabetes Res Clin Pract. 2020 Jun;164:108160. doi: 10.1016/j.diabres.2020.108160. Epub 2020 Apr 22.
2
Letter to the editor in response to the article "COVID-19 and diabetes: Can DPP4 inhibition play a role?".致编辑的信：回应文章《2019冠状病毒病与糖尿病：二肽基肽酶4抑制能否发挥作用？》
Diabetes Res Clin Pract. 2020 May;163:108163. doi: 10.1016/j.diabres.2020.108163. Epub 2020 Apr 23.
3
COVID-19 and diabetes: Is this association driven by the DPP4 receptor? Potential clinical and therapeutic implications.2019冠状病毒病与糖尿病：这种关联是由二肽基肽酶4受体驱动的吗？潜在的临床和治疗意义。
Diabetes Res Clin Pract. 2020 May;163:108165. doi: 10.1016/j.diabres.2020.108165. Epub 2020 Apr 23.
4
COVID-19 and diabetes: Can DPP4 inhibition play a role?2019冠状病毒病与糖尿病：二肽基肽酶4抑制作用能否发挥作用？
Diabetes Res Clin Pract. 2020 Apr;162:108125. doi: 10.1016/j.diabres.2020.108125. Epub 2020 Mar 26.
5
COVID-19 and comorbidities: A role for dipeptidyl peptidase 4 (DPP4) in disease severity?新型冠状病毒肺炎（COVID-19）及其合并症：二肽基肽酶 4（DPP4）在疾病严重程度中的作用？
J Diabetes. 2020 Sep;12(9):649-658. doi: 10.1111/1753-0407.13052. Epub 2020 May 27.
6
Dipeptidyl peptidase-4 (DPP4) inhibition in COVID-19.二肽基肽酶-4（DPP4）抑制剂在 COVID-19 中的作用。
Acta Diabetol. 2020 Jul;57(7):779-783. doi: 10.1007/s00592-020-01539-z. Epub 2020 Jun 6.
7
Coronavirus Infections and Type 2 Diabetes-Shared Pathways with Therapeutic Implications.冠状病毒感染与 2 型糖尿病：具有治疗意义的共同途径。
Endocr Rev. 2020 Jun 1;41(3). doi: 10.1210/endrev/bnaa011.
8
Incretin-Based Therapies Role in COVID-19 Era: Evolving Insights.基于肠促胰岛素的治疗在 COVID-19 时代的作用：不断发展的认识。
J Cardiovasc Pharmacol Ther. 2020 Nov;25(6):494-496. doi: 10.1177/1074248420937868. Epub 2020 Jul 3.
9
Management of diabetes in patients with COVID-19.2019冠状病毒病患者的糖尿病管理
Lancet Diabetes Endocrinol. 2020 Aug;8(8):666-667. doi: 10.1016/S2213-8587(20)30231-X.
10
Management of diabetes in patients with COVID-19.2019冠状病毒病患者的糖尿病管理
Lancet Diabetes Endocrinol. 2020 Aug;8(8):666. doi: 10.1016/S2213-8587(20)30226-6.

引用本文的文献

1
Developmental Impacts of Epigenetics and Metabolism in COVID-19.表观遗传学与新陈代谢在新冠病毒病中的发育影响
J Dev Biol. 2024 Feb 9;12(1):9. doi: 10.3390/jdb12010009.
2
Role of NLRP3 inflammasome in diabetes and COVID-19 role of NLRP3 inflammasome in the pathogenesis and treatment of COVID-19 and diabetes NLRP3 inflammasome in diabetes and COVID-19 intervention.NLRP3 炎性小体在 COVID-19 中的作用 NLRP3 炎性小体在 COVID-19 和糖尿病发病机制及治疗中的作用 NLRP3 炎性小体在糖尿病和 COVID-19 中的干预。
Front Immunol. 2023 Oct 5;14:1203389. doi: 10.3389/fimmu.2023.1203389. eCollection 2023.
3
The impact of preadmission/prediagnosis use of GLP-1 receptor agonists on COVID-19 mortality in patients with diabetes: A systematic review and meta-analysis.入院前/诊断前使用胰高血糖素样肽-1受体激动剂对糖尿病患者新冠病毒疾病死亡率的影响：一项系统评价和荟萃分析
Health Sci Rep. 2023 Sep 13;6(9):e1549. doi: 10.1002/hsr2.1549. eCollection 2023 Sep.
4
New thoughts on the diagnosis and treatment of patients with diabetes mellitus in relation to coronavirus disease.关于2019冠状病毒病相关糖尿病患者诊断和治疗的新思考
World J Diabetes. 2020 Nov 15;11(11):481-488. doi: 10.4239/wjd.v11.i11.481.

本文引用的文献

1
COVID-19 and diabetes: Can DPP4 inhibition play a role?2019冠状病毒病与糖尿病：二肽基肽酶4抑制作用能否发挥作用？
Diabetes Res Clin Pract. 2020 Apr;162:108125. doi: 10.1016/j.diabres.2020.108125. Epub 2020 Mar 26.
2
Liraglutide for perioperative management of hyperglycaemia in cardiac surgery patients: a multicentre randomized superiority trial.利拉鲁肽用于心脏手术患者围手术期高血糖管理的多中心随机优势试验。
Diabetes Obes Metab. 2020 Apr;22(4):557-565. doi: 10.1111/dom.13927. Epub 2019 Dec 17.
3
GLP1 Receptor Agonist Liraglutide Is an Effective Therapeutic Option for Perioperative Glycemic Control in Type 2 Diabetes within Enhanced Recovery After Surgery (ERAS) Protocols.胰高血糖素样肽-1受体激动剂利拉鲁肽是2型糖尿病患者在术后加速康复（ERAS）方案中围手术期血糖控制的有效治疗选择。
Eur Surg Res. 2018;59(5-6):349-360. doi: 10.1159/000494768. Epub 2018 Dec 11.
4
Glycaemic efficacy and safety of linagliptin compared to a basal-bolus insulin regimen in patients with type 2 diabetes undergoing non-cardiac surgery: A multicentre randomized clinical trial.与基础-餐时胰岛素方案相比，利拉利汀在接受非心脏手术的 2 型糖尿病患者中的降糖疗效和安全性：一项多中心随机临床试验。
Diabetes Obes Metab. 2019 Apr;21(4):837-843. doi: 10.1111/dom.13587. Epub 2018 Dec 17.
5
Sitagliptin for prevention of stress hyperglycemia in patients without diabetes undergoing general surgery: A pilot randomized study.西格列汀预防非糖尿病患者普外科手术应激性高血糖：一项初步随机研究。
J Diabetes Complications. 2018 Dec;32(12):1091-1096. doi: 10.1016/j.jdiacomp.2018.08.014. Epub 2018 Sep 1.
6
Postoperative inflammation and insulin resistance in relation to body composition, adiposity and carbohydrate treatment: A randomised controlled study.术后炎症与胰岛素抵抗与身体成分、肥胖和碳水化合物治疗的关系：一项随机对照研究。
Clin Nutr. 2019 Feb;38(1):204-212. doi: 10.1016/j.clnu.2018.01.032. Epub 2018 Feb 15.
7
Perioperative Hyperglycemia Management: An Update.围手术期高血糖管理：最新进展
Anesthesiology. 2017 Mar;126(3):547-560. doi: 10.1097/ALN.0000000000001515.
8
Interleukin-6 predicts inflammation-induced increase of Glucagon-like peptide-1 in humans in response to cardiac surgery with association to parameters of glucose metabolism.白细胞介素-6可预测人类因心脏手术引发炎症导致的胰高血糖素样肽-1增加，并与葡萄糖代谢参数相关。
Cardiovasc Diabetol. 2016 Feb 3;15:21. doi: 10.1186/s12933-016-0330-8.